This week on “The Top Line,” we explore the European biotech investment landscape.
Fierce Biotech’s James Waldron sits down with Maina Bhaman, a Partner at Sofinnova Capital Strategy, who provides insights into how investors are approaching the European biotech sector.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
Fierce Biotech's Fierce 15, plus a deep dive into drug commercialization strategies
[SPONSORED] Accelerate and Optimize Rare Disease Patient-Finding with AI
August 18, 2023
August 11, 2023
August 4, 2023
July 28, 2023
July 21, 2023
July 14, 2023
[Sponsored] Clinical trial technologies support recruitment efforts
July 7, 2023
June 30, 2023
June 23, 2023
June 16, 2023
June 9, 2023
[Sponsored] Addressing the patient centricity challenge with ZS Associates
June 2, 2023
May 26, 2023
May 19, 2023
May 12, 2023
[Sponsored] Inside Abbott’s beating heart of electrophysiology innovation
Create your
podcast in
minutes
It is Free
Pharmacy Podcast Network
Børsen Morgenbriefing
Sarah Westall - Business Game Changers
Startitup podcasty
Wall Street Breakfast